LBRX compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name

LBRXLB Pharmaceuticals Inc

Mkt capRevenueRevenue

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LBRXLB Pharmaceuticals Inc

IPSCCentury Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LBRX 0

None

Shared 0

No disclosed counterparties: LBRX.

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

—Fcdiunlistedsupplier

3 more · IPSC chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LBRXLB Pharmaceuticals Inc

39.10▼−1.50%· post 39.09

Mkt cap$1.2BRevenue—Revenue—

IPSCCentury Therapeutics, Inc.

1.470.00%

ClosedNov 2 '26

Mkt cap$266.2MRevenue$109MQ1 FY25Revenue$7MFY24

Compare

ClosedNov 2 '26

LBRXLB Pharmaceuticals Inc

IPSCCentury Therapeutics, Inc.

39.10▼−1.50%post 39.09

Price

1.470.00%

$1.2B

Mkt cap

$266.2M

—

Revenue

$109MQ1 FY25

—

Revenue

$7MFY24

LBRX39.10▼−1.50%vsIPSC1.470.00%ClosedNov 2 '26